| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| EHJ51659.1 | EHJ52376.1 | STRMA_0851 | STRMA_0853 | YcfA-like protein. | Putative CRISPR-associated endoribonuclease Cas2. | 0.572 |
| EHJ51659.1 | EHJ52824.1 | STRMA_0851 | STRMA_0850 | YcfA-like protein. | Hypothetical protein. | 0.975 |
| EHJ51659.1 | cas1 | STRMA_0851 | STRMA_0854 | YcfA-like protein. | CRISPR-associated endonuclease Cas1, subtype II/NMENI; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.425 |
| EHJ51659.1 | cas9 | STRMA_0851 | STRMA_0855 | YcfA-like protein. | CRISPR-associated protein Cas9/Csn1, subtype II/NMEMI; CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans- encoded small RNA (tracrRNA), endogenous ribonuclease 3 [...] | 0.425 |
| EHJ51659.1 | csn2 | STRMA_0851 | STRMA_0852 | YcfA-like protein. | CRISPR type II-A/NMEMI-associated protein Csn2. | 0.572 |
| EHJ52376.1 | EHJ51659.1 | STRMA_0853 | STRMA_0851 | Putative CRISPR-associated endoribonuclease Cas2. | YcfA-like protein. | 0.572 |
| EHJ52376.1 | EHJ52824.1 | STRMA_0853 | STRMA_0850 | Putative CRISPR-associated endoribonuclease Cas2. | Hypothetical protein. | 0.534 |
| EHJ52376.1 | cas1 | STRMA_0853 | STRMA_0854 | Putative CRISPR-associated endoribonuclease Cas2. | CRISPR-associated endonuclease Cas1, subtype II/NMENI; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.992 |
| EHJ52376.1 | cas9 | STRMA_0853 | STRMA_0855 | Putative CRISPR-associated endoribonuclease Cas2. | CRISPR-associated protein Cas9/Csn1, subtype II/NMEMI; CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans- encoded small RNA (tracrRNA), endogenous ribonuclease 3 [...] | 0.989 |
| EHJ52376.1 | csn2 | STRMA_0853 | STRMA_0852 | Putative CRISPR-associated endoribonuclease Cas2. | CRISPR type II-A/NMEMI-associated protein Csn2. | 0.926 |
| EHJ52824.1 | EHJ51659.1 | STRMA_0850 | STRMA_0851 | Hypothetical protein. | YcfA-like protein. | 0.975 |
| EHJ52824.1 | EHJ52376.1 | STRMA_0850 | STRMA_0853 | Hypothetical protein. | Putative CRISPR-associated endoribonuclease Cas2. | 0.534 |
| EHJ52824.1 | csn2 | STRMA_0850 | STRMA_0852 | Hypothetical protein. | CRISPR type II-A/NMEMI-associated protein Csn2. | 0.533 |
| cas1 | EHJ51659.1 | STRMA_0854 | STRMA_0851 | CRISPR-associated endonuclease Cas1, subtype II/NMENI; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | YcfA-like protein. | 0.425 |
| cas1 | EHJ52376.1 | STRMA_0854 | STRMA_0853 | CRISPR-associated endonuclease Cas1, subtype II/NMENI; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | Putative CRISPR-associated endoribonuclease Cas2. | 0.992 |
| cas1 | cas9 | STRMA_0854 | STRMA_0855 | CRISPR-associated endonuclease Cas1, subtype II/NMENI; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | CRISPR-associated protein Cas9/Csn1, subtype II/NMEMI; CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans- encoded small RNA (tracrRNA), endogenous ribonuclease 3 [...] | 0.975 |
| cas1 | csn2 | STRMA_0854 | STRMA_0852 | CRISPR-associated endonuclease Cas1, subtype II/NMENI; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | CRISPR type II-A/NMEMI-associated protein Csn2. | 0.958 |
| cas9 | EHJ51659.1 | STRMA_0855 | STRMA_0851 | CRISPR-associated protein Cas9/Csn1, subtype II/NMEMI; CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans- encoded small RNA (tracrRNA), endogenous ribonuclease 3 [...] | YcfA-like protein. | 0.425 |
| cas9 | EHJ52376.1 | STRMA_0855 | STRMA_0853 | CRISPR-associated protein Cas9/Csn1, subtype II/NMEMI; CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans- encoded small RNA (tracrRNA), endogenous ribonuclease 3 [...] | Putative CRISPR-associated endoribonuclease Cas2. | 0.989 |
| cas9 | cas1 | STRMA_0855 | STRMA_0854 | CRISPR-associated protein Cas9/Csn1, subtype II/NMEMI; CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans- encoded small RNA (tracrRNA), endogenous ribonuclease 3 [...] | CRISPR-associated endonuclease Cas1, subtype II/NMENI; CRISPR (clustered regularly interspaced short palindromic repeat), is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). Acts as a dsDNA endonuclease. Involved in the integration of spacer DNA into the CRISPR cassette. | 0.975 |